Long-Term Efficacy and Clinical Remission After Benralizumab Treatment in Patients with Severe Eosinophilic Asthma: A Retrospective Study.

Takanori Numata,Jun Araya,Keitaro Okuda,Hanae Miyagawa,Shunsuke Minagawa,Takeo Ishikawa,Hiromichi Hara,Kazuyoshi Kuwano

Journal of asthma and allergy（2022）

引用 8|浏览3

暂无评分

摘要

Long-term treatment with benralizumab significantly improved pulmonary function, alleviated asthma symptoms and decreased the number of exacerbations at two years in a real-world setting. The CRR may be associated with the BBC at baseline.

查看译文

关键词

benralizumab,blood basophil count,clinical remission,pulmonary function,severe asthma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要